Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 8;159(1):e4.
doi: 10.1016/j.medcle.2022.01.009. Epub 2022 Jun 29.

Reply

Ernesto Cairoli  1   2 , Gerard Espinosa  3
Affiliations

Reply

Ernesto Cairoli et al. Med Clin (Engl Ed). .
No abstract available

PubMed Disclaimer

References

    1. Mélet J., Mulleman D., Goupille P., Ribourtout B., Watier H., Thibault G. Rituximab-induced T cell depletion in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65:2783–2790. - PubMed
    1. Cairoli E., Espinosa G. Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios. Med Clin (Barc) 2021;157:247–252. doi: 10.1016/j.medcle.2021.05.003. - DOI - PMC - PubMed
    1. Moor M.B., Suter-Riniker F., Horn M.P., Aberli D., Amsler J., Möller B., et al. Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-cente, open-label study. Lancet Rheumatol. 2021:e789–797. doi: 10.1016/S2665-9913/21)00251-4. - DOI - PMC - PubMed
    1. Mrak D., Tobudic S., Koblischke M., Graninger M., Radner H., Sieghart D., et al. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Ann Rheum Dis. 2021;80:1345–1350. doi: 10.1136/annrheumdis-2021-220781. - DOI - PubMed
    1. Strangfeld A., Schäfer M., Gianfrancesco M.A., Lawson-Tovey S., Liew J.W., Ljung L., et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021;80:930–942. doi: 10.1136/annrheumdis-2020-219498. - DOI - PMC - PubMed

LinkOut - more resources